Clinical trial
Pilot Study of TTI-0102 in Cystinosis
NCT07837726 is registered in ClinicalTrials.gov with Thiogenesis Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of TTI-0102 in Cystinosis
- Lead sponsor
- Thiogenesis Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- March 31, 2027
- Enrollment
- 6 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cystinosis, nephropathic cystinosis